Ol1vebranch
commented on
$Caterpillar(CAT.US$ that plus rate cuts is good for real estate related activities
that's why this has been going up
that's why this has been going up
2
1
Ol1vebranch
voted
The short trading day of July 3rd ended with a fresh all-time highs for the $Nasdaq Composite Index(.IXIC.US$ and the $S&P 500 Index(.SPX.US$.
UPDATE: The Nasdaq closed at a fresh high, at 18,188.30, and the S&P 500 closed at 5,537.02.
Anyway, my name is Kevin Travers, here are stories from the moomoo herd on Wall Street today.
$Paramount Global-B(PARA.US$ was the highest gainer on the S&P 500, climbing 9% after news of its deal to sell off Nati...
UPDATE: The Nasdaq closed at a fresh high, at 18,188.30, and the S&P 500 closed at 5,537.02.
Anyway, my name is Kevin Travers, here are stories from the moomoo herd on Wall Street today.
$Paramount Global-B(PARA.US$ was the highest gainer on the S&P 500, climbing 9% after news of its deal to sell off Nati...
![Fresh High for a Short Day | Herd on Wall Street](http://1500015405.vod2.myqcloud.com/f7703b98vodtransuse1500015405/e10ce6fb1253642700133918528/coverBySnapshot/coverBySnapshot_10_0.jpg)
50
7
Ol1vebranch
liked
$Ovid Therapeutics(OVID.US$
Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations
Ovid Therapeutics and Graviton Bioscience announced positive Phase 1 trial results for their OV888/GV101 capsule, a potential first-in-class therapy for cerebral cavernous malformations (CCM). The trial met its primary objective by demonstrating a favorable safety and to...
Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations
Ovid Therapeutics and Graviton Bioscience announced positive Phase 1 trial results for their OV888/GV101 capsule, a potential first-in-class therapy for cerebral cavernous malformations (CCM). The trial met its primary objective by demonstrating a favorable safety and to...
1
Ol1vebranch : CAT is a stock that is always going up over time. Trump has nothing to do with anything.